Myocardial Infarction News and Research

RSS

Vigorous exercise linked to lower dementia risk in hypertensive individuals

The effect of vigorous physical activity (VPA) on the risk of incident mild cognitive impairment (MCI) and probable dementia.

10 Jun 2024

Novel insights into the underlying, contributing, and direct causes of death in Australia

Coronary heart disease (CHD) was involved in 1 in 5 deaths in 2022 when using all of the information included on the medical death certificate, according to a new Australian Institute of Health and Welfare (AIHW) release revealing what Australians are most likely to die from.

8 Jun 2024

Moderate choline intake lowers heart disease risk

A recent study from BMC Public Health found that moderate dietary choline intake is associated with a reduced risk of atherosclerotic cardiovascular disease (ASCVD) among US adults.

4 Jun 2024

Studies underscore the relationship between narcolepsy and cardiovascular disease

Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events.

4 Jun 2024

Coronary arterial inflammation linked to high cardiac event risk even without CAD

Researchers in The Lancet highlight coronary arterial inflammation's role in increasing major adverse cardiac events and cardiovascular deaths, irrespective of coronary artery disease presence.

3 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Semaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.

28 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

Are step counts as effective as time-based exercise in boosting health?

Monitoring physical activity with either step counts or time spent exercising shows similar benefits in reducing cardiovascular disease and all-cause mortality among women in their 60s. Both methods support health guidelines and personal preference.

23 May 2024

Study finds microplastics in blood clots, linking them to higher risk of heart attacks and strokes

A study in EBioMedicine reveals significant microplastic concentrations in thrombi from major blood vessels, linking microplastic levels to increased risk and severity of thrombotic events.

22 May 2024

Eating more potatoes may lower your risk of heart disease and early death, study finds

A Norwegian study found that higher potato consumption moderately reduces the risk of all-cause and cardiovascular disease mortality in adults.

21 May 2024

Are fish oil supplements associated with cardiovascular disease?

The effects of using fish oil supplements on the clinical progression of cardiovascular disease.

21 May 2024

Men face greater risk of cardiovascular and kidney issues due to diabetes, study shows

Researchers investigated gender disparities in microvascular and macrovascular complication rates among individuals with diabetes.

17 May 2024

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke and cardiovascular events in patients with non-cardioembolic stroke in the primary intention-to-treat analysis.

16 May 2024

Interpreter access associated with Heart School participation among foreign-born post-heart attack patients

After a heart attack, foreign-born people are less likely to attend a relapse-preventing Heart School than native-born patients.

15 May 2024

Researchers find beneficial effects of a novel drug in the management of myocardial infarction

Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital(iCor) have found beneficial effects of the novel drug Sacubitril/Valsartan in the management of myocardial infarction (MI).

14 May 2024

Heightened risk of adverse neonatal outcomes from prenatal exposure to both cannabis and nicotine

A recent JAMA Network Open study found that combined prenatal use of nicotine and cannabis significantly increases risks for adverse perinatal outcomes, such as higher rates of hypertensive disease, preterm delivery, and elevated infant mortality compared to using neither or only one substance.

9 May 2024

High blood pressure in youth linked to elevated risk of heart conditions

Youth with high blood pressure are nearly four times more likely to be at long-term risk of serious heart conditions including stroke and heart attack, according to a new study.

3 May 2024

Study shows radial arterial access superiority in coronary interventions

New data demonstrate the superiority of radial arterial access compared to femoral arterial access for coronary interventions.

2 May 2024

New scoring system identifies risks in coronary artery interventions

New data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), based on three simple baseline angiographic findings, could help to rapidly discriminate lesions at risk of side branch (SB) occlusion during LM bifurcation percutaneous coronary intervention (PCI) – reducing risk during the procedure.